Overview
Catherine Rytting is a Physician Assistant in Houston, Texas. Ms. Rytting is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
Kelsey-Seybold Medical Group, PLLC
Hafsa Ishaq is a Physician Assistant in Sugar Land, Texas. Ms. Ishaq is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Smoldering Multiple Myeloma, Saddle Pulmonary Embolism, BRCA Positive Breast Cancer, and HER2 Negative Breast Cancer. Ms. Ishaq is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- BRCA Positive Breast CancerMs. Rytting isAdvanced. Learn about BRCA Positive Breast Cancer.
- HER2 Negative Breast CancerMs. Rytting isAdvanced. Learn about HER2 Negative Breast Cancer.